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Several studies have shown that deletion of the nef gene of simian immunodeficiency virus (SIV) and simian–human
immunodeficiency virus (SHIV) results in attenuated viruses. However, studies have not critically examined trafficking of
attenuated viruses to the central nervous system (CNS) at early stages after inoculation. In this study, we investigated the
colocalization of pathogenic and vpu-negative, nef-interrupted SHIVs at early stages following inoculation. The first virus,
designated SHIV50OLNV, was isolated from the lymph node of a pig-tailed macaque which developed severe CD4
 T cell loss
and neurological disease. The second virus was a molecularly cloned virus in which the vpu gene was deleted and the gene
for the enhanced green fluorescent protein from the jellyfish Aequoria victora had been inserted in-frame within the nef gene
of the pathogenic SHIVKU-1bMC33 (designated SHIVKU-1bEGFP). Three pig-tailed macaques were inoculated intravenously with
equivalent amounts of two viruses, two macaques were inoculated with SHIVKU-1bEGFP, and two macaques were inoculated with
SHIV50OLNV. The peripheral blood mononuclear cells (PBMCs) were isolated from bleeds obtained 3, 7, 10, and 14 days
postinoculation and monitored for syncytia-inducing virus and for fluorescent cells. Virus was detected in the PBMCs as early
as 3 days postinoculation and was present throughout the course of this short-term study. At 14 days postinoculation, the
macaques were sacrificed and examined for virus in lymphoid tissues and different regions of the CNS following necropsy.
Our results revealed the presence of both viruses in lymphoid and CNS tissues, although SHIV50OLNV was present to a much
greater extent. Histological examination revealed that one macaque displayed signs of meningitis and all three macaques
developed massive cortical astrocyte activation as demonstrated by immunostaining for glial fibrillary acidic protein, but only
limited microglial activation. In the two macaques inoculated with SHIV50OLNV, astrocyte activation similar to that in the
macaques inoculated with both viruses was observed while no astrocyte activation was observed in macaques inoculated
with SHIVKU-1bEGFP. Thus, this study demonstrates that SHIVs with an intact nef(SHIV50OLNV) as well as those lacking a vpu genele of in
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Human immunodeficiency virus type 1 (HIV-1) is best
known for its ability to cause a profound immune defi-
ciency known as AIDS. In addition to immune dysfunc-
tion, this virus is known to invade the central nervous
system (CNS) and cause the neurological disease AIDS
cognitive/motor complex or AIDS dementia complex.
HIV-1-induced neurological disease is generally a late-
stage manifestation of the disease, and the lesions as-
sociated with HIV-1 encephalitis (HIV-E) include perivas-
cular infiltration with mononuclear cells, microglial nod-
ules, astrocytosis, and multinucleated giant cells,
although the last type of lesion is not universally ob-
served in all cases of HIV-E (Budka, 1991; Price et al.,
1988). It is known that HIV-1 probably invades the CNS
early after infection, but the cells which traffic the virus
139across the blood–brain barrier are currently unknown
(Resnick et al., 1988; Davis et al., 1992). Some evidence
suggests that infected macrophages in the peripheral
blood are likely the mode of transport for the virus to
enter the CNS (Williams et al., 2001). Disruptions of the
tight junctions in the blood–brain barrier, which would
permit the migration of infected macrophages into the
CNS, have been observed in patients with HIV-1 enceph-
alitis (Dallasta et al., 1999). The viruses that have been
isolated from the brains of HIV-1 patients with encepha-
litis are generally macrophage-tropic, and the brain mi-
croglia are the major source of productive viral replica-
tion in the CNS (Cunningham et al., 1997; Smit et al.,
2001; Williams et al., 2001). In addition to infection of
microglia, HIV-1 is known to infect astrocytes, although
replication appears to be nonproductive or poorly pro-
ductive (Bagasra et al., 1996; Brack-Werner, 1999; Sabri et
al., 1999).and with a nonfunctional nef gene (SHIVKU-1bEGFP) are capab
causing reactive astrocytosis early after inoculation. © 20
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Studies have shown that both T cell-tropic SIVmac and
dual-tropic SIVmac enter the CNS early after inoculation
and that development of SIV-E correlates with viral loads
in the cerebrospinal fluid (CSF) (Zink et al., 1999). While
investigators believe that infected activated T cells or
monocytes traffic virus to the CNS compartment, other
studies suggest that cell-free virus could enter the CNS
by directly infecting the microvascular endothelial cells
(Moses et al., 1993; Mankowski et al., 1994). In another
study using the SIV/macaque model, it was shown that
disruption of tight junctions was associated with the
accumulation of perivascular macrophages in cases of
SIV encephalitis (Luabeya et al., 2000). Recent studies
have shown that the two main coreceptors for HIV,
CXCR4 and CCR5, are expressed at high levels on mi-
crovascular endothelial cells (Berger et al., 1999). Addi-
tional studies in the SIV model suggest that the virus can
infect brain capillary endothelial cells via a CD4-inde-
pendent pathway (Edinger et al., 1997).
The simian–human immunodeficiency virus (SHIV)
contains the tat, rev, vpu, and env of HIV-1 in a genetic
background of SIVmac239 (Li et al., 1992). Pathogenic
SHIVs have been derived in several laboratories and are
associated with high virus burdens, rapid loss of circu-
lating CD4 T cells, and depletion of T cell-rich areas of
the thymus, lymph nodes, and spleen (Joag et al., 1996;
Reimann et al., 1996; Shibata et al., 1997; Luciw et al.,
1999). Macaques inoculated with pathogenic SHIVs gen-
erally succumb to their disease within 6–8 months, and
similar to the SIVmac model, SHIV-inoculated macaques
can develop neurological disease and a neuropathology
that is similar to SIV-E (Raghavan et al., 1997; Liu et al.,
1999; McCormick-Davis et al., 2000). In this report, we
have utilized two viruses to investigate the initial stages
of infection in the SHIV/macaque model. We recently
described an uncloned cell-free virus, SHIV50OLNV, iso-
lated from the lymph node of a pig-tailed macaque (Ma-
caca nemestrina) which developed severe CD4 T cell
loss and neurological disease. SHIV50OLNV causes severe
CD4 T cell loss within 2 weeks after inoculation of
pig-tailed macaques (Singh et al., 2001). Another virus
was constructed, SHIVKU-1bEGFP, in which the vpu gene was
deleted and the Aequoria victora gene for the enhanced
green fluorescent protein (EGFP) was inserted in-frame
within the viral nef gene. Thus, the SHIVKU-1bEGFP has an
interrupted nef gene. In this short-term study, we show
that not only is an intact vpu gene dispensable
(SHIV50OLNV) for invasion of the CNS, but that a SHIV
lacking functional vpu and nef genes (SHIVKU1bEGFP) is also
neuroinvasive.
RESULTS
Cells producing infectious virus and fluorescence
were recovered from macaques inoculated with
SHIV50OLNV and SHIVKU-1bEGFP or SHIVKU-1bEGFP alone
In an outbred species such as macaques the in vivo
effects of a virus can vary from animal to animal. There-
fore, we chose to evaluate the ability of the viruses to
invade and replicate in various organs within the same
animals. An equivalent amount (104 TCID50) of each virus,
SHIV50OLNV and SHIVKU-1bEGFP, was inoculated intravenously
into three pig-tailed macaques (AX67, CB4R, and CB4W).
Blood was collected approximately every 3 days follow-
ing inoculation, and peripheral blood mononuclear cells
(PBMCs) were isolated and assayed for cells producing
infectious cytopathic virus and for the presence of fluo-
rescent cells, which was indicative of infection with virus
expressing the EGFP gene (Fig. 1A). As shown in Table
1, the infectious center assays (ICA) recovered cells
producing infectious virus as early as 3 days postinocu-
lation in one macaque (10 per 106 PBMC in CB4R) with
the largest amounts at 10 days postinoculation in two of
the macaques (10,000 per 106 PBMC in AX67 and CB4W).
The largest number of cells producing infectious virus in
macaque CB4R was observed at the time of necropsy, 14
days postinoculation (10,000 per 106 PBMC). The same
assay was used to examine the presence of intact
FIG. 1. Detection of SHIVKU-1bEGFP in the PBMCs and lymphoid tissues from macaque AX67 at necropsy. (A) PBMCs isolated as described under
Materials and Methods. (B) Mesenteric lymph node fixed in 2% paraformaldehyde and frozen sections examined by fluorescence microscopy. (C)
Thymus tissue fixed in 2% paraformaldehyde and frozen sections examined by fluorescence microscopy. No fluorescence was detected in isolated
PBMCs or tissues from uninfected macaques (data not shown).
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SHIVKU-1bEGFP by fluorescence microscopy. Using this as-
say, fluorescent cells were detected at 7 days postinocu-
lation (10 to 100 per 106 PMBC) in two of the animals,
AX67 and CB4R. The largest number of fluorescent cells
was found in macaque CB4R at 10 days postinoculation
(10,000 per 106 PBMC) and at necropsy in the remaining
two macaques (100 to 1000 per 106 PBMC in AX67 and
CB4W, respectively). At necropsy, thymus, spleen, and
lymph node cells were also assayed for cells producing
infectious cytopathic virus and fluorescence. One thou-
sand to 10,000 cells per 106 PBMC were shown to pro-
duce infectious virus and 10 to 10,000 cells per 106 PBMC
were fluorescent.
In addition to the macaque inoculated with SHIV50OLNV
and SHIVKU-1bEGFP, two macaques (CM58 and CM4M)
were inoculated with SHIVKU-1bEGFP alone. As shown in
Table 2, the ICA recovered cells producing infectious
virus as early as 3 days postinoculation in both ma-
caques (10 per 106 PBMC in both CM58 and CM4M) with
the largest amounts at 9–10 days postinoculation in two
of the macaques (10,000 per 106 PBMC in CM58 and
1000 per 106 PBMC in CM4M). At necropsy, thymus,
spleen, and lymph node cells were also assayed for cells
producing infectious cytopathic virus. We found that from
100 to 10,000 cells per 106 cells isolated from these
organs produced cytopathic virus. These results demon-
strate that SHIVKU-1bEGFP was present in isolated PBMCs
and had invaded the lymphoid organs within 2 weeks
postinoculation.
The results from two macaques (CM59 and CM6G)
that were also inoculated with SHIV50OLNV are shown in
Table 2. ICA recovered cells producing infectious, cyto-
pathic virus as early as 7 days postinoculation (100 per
106 PBMC and 1000 per 106 PBMC in CM59 and CM6G,
respectively). The largest number of cells producing in-
fectious, cytopathic virus occurred for both macaques at
day 14 postinoculation. At necropsy, cells isolated from
the thymus, spleen, and lymph nodes all produced large
amounts of virus. These results confirmed that SHIV50OLNV
had infected lymphoid organs to a greater extent than in
macaques inoculated with SHIVKU-1bEGFP.
Both SHIV50OLNV and SHIVKU-1bEGFP were present in the
visceral organs
Histological examination of lymphoid organs from the
macaques inoculated with SHIV50OLNV and SHIVKU-1bEGFP
TABLE 1
Numbers of Cells Producing Infectious, Cytopathic Virus and Numbers of Fluorescent Cells in PBMCs, Thymus,
Spleen, or Lymph Nodes from Macaques Inoculated with SHIV50OLNV and SHIVKU-1EGFP
Macaque
AX67 CB4R CB4W
CPEa EGFPb CPEa EGFPb CPEa EGFPb
PBMCsc
2 to 3 0 0 10 0 0 0
7 10,000 10 1,000 100 1,000 0
9 to 10 10,000 0 1,000 10,000 10,000 1000
14 1,000 100 10,000 1,000 1,000 1000
Thymusd 1,000 10 10,000 10,000 1,000 1000
Spleend 10,000 100 100 10,000 1,000 1000
Lymph noded 1,000 100 10,000 1,000 10,000 1000
a Number of cells producing infectious virus per 106 PBMCs in ICA using cytopathology (fusion) as the indicator.
b The number of fluorescent cells per 106 isolated PBMCs, thymus, spleen, or lymph node cells.
c The number of days postinoculation that PBMCs were isolated.
d Thymus, spleen, and lymph node cells were isolated at the time of necropsy.
TABLE 2
Numbers of Cells Producing Infectious, Cytopathic Virus in PBMCs,
Thymus, Spleen, or Lymph Nodes from Macaques Inoculated with
SHIV50OLNV or SHIVKU-1EGFP
Macaque
CM59a CM6Ga CM58b CM4Mb
PBMCsc
2 to 3 0 0 10 10
7 100 1,000 ND 100
9 to 10 1,000 1,000 10,000 1,000
14 1,000 10,000 1,000 1,000
Thymusd 10,000 10,000 1,000 10,000
Spleend 10,000 10,000 1,000 10,000
Lymph noded 10,000 10,000 10,000 100
a Inoculated with SHIV50OLNV.
b Inoculated with SHIVKU-1bEGFP.
c Number of cells producing infectious virus per 106 PBMCs in ICA
using cytopathology as the indicator. Numbers refer to the day cells
were collected.
d Thymus, spleen, and mesenteric lymph node cells were isolated at
the time of necropsy.
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revealed mild lymphadenopathy in the mesenteric lymph
nodes in one animal (AX67) and lymphoid depletion of
the thymus in another animal (CB4R) (data not shown).
Examination of the lymphoid tissues by fluorescence
microscopy revealed that EGFP was expressed in the
lymph nodes and thymus of the macaques (Figs. 1B and
1C). In addition, visceral organs were examined for the
presence of viral sequences using nested PCR tech-
niques. Figure 2 shows a representative example of the
results observed in macaque AX67 and Table 3 summa-
rizes the data of all three macaques. The results shown
indicate that all visceral organs were positive for the viral
gag, demonstrating that one or both of the viruses had
infected these tissues. However, nested PCR for egfp in
macaque AX67 indicated that SHIVKU-1bEGFP was found
only in the kidney and lymph node tissues examined
(three of eight tissues), suggesting that only SHIV50OLNV
was present in the liver, lung, small intestine, spleen, and
thymus. All visceral organs were positive for the pres-
ence of 2-long terminal repeat (LTR) circles, indicating
that active viral replication was occurring in these organs
at the time of necropsy. Table 3 displays the results
observed in macaques CB4R and CB4W. Like AX67, DNA
samples isolated from the visceral organs of CB4R were
positive for viral gag sequences but only the spleen,
thymus, and lymph nodes were positive for the gene
encoding EGFP (four of eight). Examination of the same
DNA samples for 2-LTR circles revealed that five of eight
tissues examined were positive (kidney, small intestine,
spleen, and mesenteric and inguinal lymph nodes). As
seen in the other two macaques, viral gag sequences
were amplified in all visceral organs examined for CB4W.
Examination of visceral organs for the egfp gene re-
vealed that four of eight were positive (liver, thymus, and
mesenteric and inguinal lymph nodes). In addition, all of
the visceral organs except the kidney were positive for
2-LTR circle sequences (seven of eight). These results
indicate that: (a) SHIV50OLNV was widely distributed
throughout the visceral organs at the time of necropsy
and (b) the nef-interrupted virus (SHIVKU-1bEGFP) was
present in the lymph nodes from all macaques and in
thymus of two of three macaques.
We also examined the distribution of virus in ma-
caques inoculated with SHIVKU-1bEGFP or SHIV50OLNV. Histo-
logical examination of tissues from the macaques inoc-
ulated with only SHIV50OLNV revealed in some lymphoid
depletion of lymphoid organs, most notably in the thy-
mus. Examination of the tissue DNAs from these two
macaques revealed that seven of eight and eight of eight
visceral organs were positive for viral gag and 2-LTR
sequences in CM59 and CM6G, respectively (Table 3).
These results indicate that the SHIV50OLNV was widely
disseminated, similar to the results from macaques in-
oculated with both viruses. Histological examination of
lymphoid organs from the macaques inoculated with
only SHIVKU-1bEGFP revealed no lesions associated with
lymphoid depletion (data not shown). Examination of the
lymphoid tissues by fluorescence microscopy revealed
that EGFP was expressed in cells derived from the lymph
nodes, spleen, and thymus of the macaques. Examina-
tion of tissue DNAs from these two macaques revealed
that six of eight visceral organs were positive for the viral
gag sequences (only kidney and liver were negative) in
macaque CM58 and that seven of eight visceral organs
were positive for viral gag sequences (only kidney was
negative) in macaque CM4M, demonstrating that SHIVKU-
1bEGFP had infected these lymphoid tissues (Table 3). The
TABLE 3
Number of Visceral Organs Positive for Viral gag, 2-LTR Se-
quences, and egfp Using Nested PCR in Macaques Inoculated with
SHIV50OLNV and SHIVKU-1EGFP, SHIVKU-1EGFP, or SHIV50OLNV Alone
Macaque
Numbers of visceral organs positive by PCR for:
Viral gag
(viral genome)
2-LTR circles
(actively replicating virus) egfp
AX67a 8/8 8/8 3/8
CB4Ra 8/8 5/8 4/8
CB4Wa 8/8 7/8 4/8
CM58b 6/8 4/8 ND
CM4Mb 7/8 5/8 ND
CM59c 7/8 6/8 ND
CM6Gc 8/8 8/8 ND
Note. ND, not done.
a Inoculated with SHIV50OLNV and SHIVKU-1EGFP.
b Inoculated with SHIVKU-1EGFP.
c Inoculated with SHIV50OLNV.
FIG. 2. PCR analysis of visceral organ tissue DNA from macaque
AX67 for gag, egfp, and 2-LTR circle sequences. DNA was extracted
from the visceral organs and used in nested PCR using the appropriate
primers for SIV and SHIV as described under Materials and Methods.
Ten microliters of the reaction products was run in a 1.5% agarose gel
(gag and 2-LTR) or a 2% agarose gel (egfp) stained with ethidium
bromide. (A) Agarose gel showing the presence of viral gag sequences
in the visceral organs of macaque AX67. Lane 1, kidney; lane 2, liver;
lane 3, lung; lane 4, small intestine; lane 5, spleen; lane 6, thymus; lane
7, inguinal lymph node; lane 8, mesenteric lymph node; lane 9, positive
control; and lane 10, negative control. (B) Agarose gel showing the
presence of egfp sequences in the visceral organs of macaque AX67.
Lanes 1–8 are the same as in A; lane 9, negative control. (C) Agarose
gel showing the presence of 2-LTR circle sequences. The lanes are the
same as in A.
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presence of 2-LTR circles was detected in four of eight
visceral organs of CM58 (mesenteric lymph node, ingui-
nal lymph node, spleen, and thymus were positive) while
2-LTR circles were found in five of eight visceral organs
examined for CM4M, indicating that active viral replica-
tion was ongoing in these lymphoid organs at the time of
necropsy.
SHIV50OLNV and SHIVKU-1bEGFP traffic to the CNS early
after inoculation
In addition to the visceral organs, one half of the brain
of the three macaques was dissected into 15 regions and
examined for the presence of viral sequences (Table 4).
Figure 3 shows a representative example of the results
from macaque AX67. As seen in the visceral organs, all of
the 15 CNS regions examined were positive for viral gag
sequences. Of 15 regions positive for viral gag se-
quences, 8 had actively replicating virus as determined
by the presence of 2-LTR circle sequences. As seen in
Fig. 3, the size of the amplified 2-LTR circles was heter-
ogenous and sequence analysis revealed deletions of
varying sizes at the LTR junctions (data not shown).
Examination of the same regions for the presence of the
nef-interrupted virus revealed that 2 of 15 regions were
positive for the egfp. The majority of the CNS regions
examined from CB4R were positive for viral gag se-
quences (13 of 15), 4 regions were positive for 2-LTR
circle sequences (motor cortex, occipital cortex, tempo-
ral cortex, and cervical spinal cord), and egfp sequences
were detected in 4 of the 15 regions (motor cortex,
parietal cortex, pons, and cervical spinal cord). Thirteen
of the 15 CNS regions examined from CB4W were pos-
itive for viral gag sequences, 5 regions were positive for
2-LTR circle sequences (motor cortex, occipital cortex,
corpus callosum, medulla, and thoracic spinal cord), and
4 regions were positive for egfp sequences (corpus cal-
losum, basal ganglia, thoracic spinal cord, and lumbar
spinal cord). These results indicate that at 2 weeks, both
of the viruses had invaded the CNS and that active viral
replication had occurred in some regions of the CNS.
We also examined tissue DNA samples from the CNS
for the presence of viral nef sequences (Fig. 3D). PCR
results indicated that the viral nef genes amplified from
the CNS regions of the three macaques varied in size
and many contained multiple bands. However, the ma-
jority of the CNS regions were positive for a viral nef
species that corresponded to the expected size of intact
nef from SHIV50OLNV. No bands were observed that corre-
sponded to the expected size of the nef/egfp (1.5 kb).
This was not altogether surprising as the smaller frag-
ments will be preferentially amplified when compared to
the approximately 1.5-kb nef/egfp fragment. To confirm
the presence or absence of nef/egfp sequences, South-
ern blot analysis was performed on the nef-amplified
products using a radiolabeled egfp probe. Our results
indicated that two CNS regions contained nef sequences
from macaque CB4R which hybridized with egfp and no
regions were hybridized with egfp in macaques AX67
FIG. 3. PCR analysis of CNS tissue DNA from macaque AX67 for gag,
egfp, and 2-LTR circle sequences. DNA was extracted from the 15 CNS
regions and used in nested PCR using the appropriate primers for SIV
and SHIV as described under Materials and Methods. Ten microliters
of the reaction products was run in a 1.5% agarose gel (gag and 2-LTR)
or a 2% agarose gel (egfp) stained with ethidium bromide. (A) Agarose
gel showing the presence of viral gag in the 15 CNS regions of
macaque AX67. (B) Agarose gel showing the presence of egfp se-
quences in the 15 CNS regions of macaque AX67. (C) Agarose gel
showing the presence of 2-LTR circle sequences in the 15 CNS regions
of macaque AX67. (D) Agarose gel showing the presence of nef se-
quences in the 15 CNS regions of macaque AX67. Lane 1, frontal cortex;
lane 2, motor cortex; lane 3, parietal cortex; lane 4, occipital cortex; lane
5, temporal cortex; lane 6, hippocampus; lane 7, corpus callosum; lane
8, basal ganglia; lane 9, midbrain; lane 10, pons; lane 11, medulla; lane
12, cerebellum; lane 13, cervical spinal cord; lane 14, thoracic spinal
cord; lane 15, lumbar spinal cord; lane 16, positive control; lane 17,
negative control.
TABLE 4
Number of CNS Regions Positive for Viral gag, 2-LTR Sequences,
and egfp Using Nested PCR in Macaques Inoculated with SHIV50OLNV
and SHIVKU-1EGFP, SHIVKU-1EGFP, or SHIV50OLNV Alone
Macaque
Numbers of CNS regions positive by PCR for:
Viral gag
(viral genome)
2-LTR circles
(actively replicating virus) egfp
AX67a 15/15 8/15 2/15
CB4Ra 13/15 4/15 4/15
CB4Wa 13/15 5/15 4/15
CM58b 7/14 2/14 ND
CM4Mb 9/14 2/14 ND
CM59c 8/14 2/14 ND
CM6Gc 13/14 9/14 ND
Note. ND, not done.
a Inoculated with SHIV50OLNV and SHIVKU-1EGFP.
b Inoculated with SHIVKU-1EGFP.
c Inoculated with SHIV50OLNV.
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and CB4W (data not shown). These data were consistent
with the PCR data indicating a limited distribution of egfp
sequences amplified from the different regions of the
CNS of all three macaques (Table 3). Taken together
these results indicate that the nef intact virus (SHIV50OLNV)
was more neuroinvasive than the nef-interrupted
SHIVKU-1bEGFP virus.
Since we were able to detect the SHIVKU-1bEGFP virus in
a limited number of regions within the CNS, we wanted
to determine if trafficking of this virus was due to the
presence of the SHIV50OLNV; thus we examined the CNS
from macaques inoculated with SHIVKU-1bEGFP (macaque
CM4M or CM58) or SHIV50OLNV alone (CM59 or CM6G). As
shown in Table 4, we were able to detect gag sequences
in 7 of 14 regions from CM58 and in 9 of 14 regions from
CM4M. Examination of the same regions for the pres-
ence of 2-LTR circles revealed that they were present in
2 of 14 regions in CM58 and in 2 of 14 regions from
CM4M. These results indicate that SHIVKU-1bEGFP alone
was capable of trafficking to the CNS early after inocu-
lation. The results of inoculation of two macaques with
SHIV50OLNV are shown in Table 4. We found SHIV50OLNV in 8
of 14 regions of the CNS from macaque CM59 and in 13
of 14 regions from macaque CM6G. The presence of
2-LTR sequences, indicative of active virus replication,
was found in 9 of 14 regions of the CNS from macaque
CM6G and 2 of 14 regions of the CNS from macaque
CM59. In addition, we were able to recover infectious
cytopathic virus from the cerebrospinal fluid taken at
necropsy. Taken together, the data from these three
groups of macaques indicate that both viruses were
capable of trafficking to the CNS early after infection with
the pathogenic SHIV50OLNV being present in more regions
of the CNS than SHIVKU-1bEGFP.
We also analyzed the proviral loads in the CNS and
lymphoid tissues of macaques inoculated with either
SHIV50OLNV or SHIVKU-1bEGFP. The results indicate that viral
loads in three regions of the CNS from a macaque
(CM6G) inoculated with SHIV50OLNV were generally 10-fold
higher than the same regions from a macaque (CM58)
that was inoculated with SHIVKU-1bEGFP (Fig. 4). While neu-
roinvasion of the CNS appeared to be more extensive in
the macaque inoculated with SHIV50OLNV with respect to
viral genome copy number, it was far below what was
seen in the thymus tissue (Fig. 4).
Inoculation of pig-tailed macaques with SHIVKU-1bEGFP
resulted in astrocyte activation
Histological examination of the CNS revealed no le-
sions indicative of lentiviral encephalitis such as micro-
glial nodules or giant cells, although histological exam-
ination of brain sections from one macaque, CB4W, re-
vealed perivascular mononuclear infiltration in the pia
matter around the lumbar spinal cord and small perivas-
cular cuffs in the parietal cortex. Another histopatholog-
ical feature of SIV and HIV neurological disease is the
presence of a reactive astrocytosis and microglial acti-
vation (Chakrabarti et al., 1991; Budka, 1991). Therefore,
we examined the brains of these macaques for astrocy-
tosis by immunohistochemical staining for glial fibrillary
acidic protein (GFAP) and microglial activation by
staining for MHC-II. All three monkeys infected with
SHIVKU-1bEGFP and SHIV50OLN exhibited a massive increase
in numbers of GFAP-positive cells in cerebral cortex and
subcortical white matter (Fig. 5). The intensity of GFAP
immunoreactivity was also increased compared to that in
the normal brain. Activated astrocytes were found to be
concentrated in the subpial glia limitans and layers I, IV,
lower V, and upper VI, giving the cortex a laminar pattern
(Figs. 5D). Large numbers of activated astrocytes stain-
ing intensely for GFAP were observed in subpial glia
limitans beneath the pia membrane throughout the ce-
rebral cortex. Increased numbers of GFAP-positive cells
were also observed in the vicinity of blood vessels and in
the area subjacent to the white matter. White matter of
the infected macaques exhibited a marked increase in
the intensity of GFAP staining in both the soma and the
processes of astrocytes. The number of activated astro-
cytes was also increased within the white matter com-
pared to the normal macaques (Figs. 5C and 5F). The
results of the increased GFAP immunostaining were con-
firmed by analysis of tissue RNA samples isolated from
the parietal cortex of infected and uninfected macaques
for the presence of GFAP mRNA using RT-PCR. The
results clearly showed an increase in mRNA from in-
fected macaques (data not shown). Unlike our results for
GFAP, immunostaining for MHC-II revealed only occa-
sional cells resembling monocyte/microglia and few in-
terdigitating cells beneath the pia matter and around
blood vessels (data not shown). Occasional microglial
cells that stained for MHC-II were also observed in the
cortex but their number was comparable to that in the
FIG. 4. Analysis of viral loads in the CNS and lymphoid tissues from
a macaque inoculated with SHIV50OLNV or SHIVKU-ibEGFP. Total cellular DNA
was extracted from the tissues and used to quantitate the number of
viral copies per 106 genome equivalents as described under Materials
and Methods. THY, thymus; MC, motor cortex; MD, midbrain; CSC,
cervical spinal cord.
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sections from the normal macaque and from other age-
matched controls (Sheffield and Berman, 1998). Thus, the
results of the immunohistochemical staining indicate
that early neuroinvasion by SHIV was associated with a
massive reactive astrocytosis but no significant micro-
glial activation.
To determine whether this astrocyte activation was a
property of neuroinvasion by SHIV50OLNV or SHIVKU-1bEGFP,
macaques inoculated with SHIVKU-1bEGFP or SHIV50OLNV
were also examined for histological lesions and astro-
cyte activation. We found that one of two macaques
(CM6G) had developed meningitis, which correlated well
with the large number of regions that were positive for
2-LTR circles from this macaque. Our results indicate
that both macaques inoculated with SHIV50OLNV had the
same astrocytic activation pattern that was observed in
macaques inoculated with both viruses. In contrast, the
two macaques inoculated with SHIVKU-1bEGFP exhibited an
immunostaining pattern for astrocyte activation similar to
that for the uninfected control macaque. Thus, these
results indicate that the reactive astrocytosis associated
with SHIV neuroinvasion in the dually inoculated ma-
caques was due to the pathogenic SHIV50OLNV.
DISCUSSION
Much of our current knowledge of the initial stages of
neuroinvasion by lentiviruses has come from studies in
the SIV/macaque model (Chakrabarti et al., 1991; Lack-
ner et al., 1994; Zink et al., 1999). In one study, viral
antigen and RNA were detected within the brains of
SIV-infected macaques within 7 days postinoculation
(Chakrabarti et al., 1991). In another study, it was shown
that animals inoculated with pathogenic SIVmac and sac-
rificed at 2 weeks postinoculation had mild meningitis
and some showed signs of perivascular cuffing and giant
cell formation (Lackner et al., 1994). Additional studies
showed that juvenile rhesus macaques inoculated with
SIVmac239 developed cortical astrocytosis as early as 2
weeks postinoculation (Weihe et al., 1993), that SIVmac
was present in the CSF early after inoculation, and that
large amounts of viral RNA in the CSF after the acute
stage of infection correlated with the progression to
encephalitis (Lackner et al., 1994; Zink et al., 1999).
In addition to the SIV/macaque model for neuroAIDS,
other investigators have shown that pathogenic SHIVs
can cause neurologic disease following inoculation of
pig-tailed and rhesus macaques (Raghavan et al., 1997;
FIG. 5. GFAP immunoreactivity in cerebral cortex and subcortical white matter of uninfected (A–C) and SHIV-infected (D–F) pig-tailed macaques
at 2 weeks postinoculation. (D) Increased numbers of GFAP-positive astrocytes were distributed in layers I, IV, lower V, and upper VI of cortex and
glia limitans. In contrast, few cells were evident in a comparable section of normal brain (A). (E) Subpial glia limitans exhibiting GFAP-positive cells
forming a thick layer in all areas of cortex. Large numbers of activated astrocytes are also evident around the blood vessels beneath the pia matter
and in the cortex. Very few GFAP-positive cells were evident in the comparable section of the cortex from a normal macaque (B). (F) Massive increase
in immunoreactivity of GFAP is evident in the subcortical white matter in the SHIV-infected macaque, whereas comparable sections from the
uninfected brain show that the number of cells and intensity of GFAP staining are much reduced (C).
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Liu et al., 1999; McCormick-Davis et al., 2000). However,
no study has critically evaluated SHIV neuroinvasion at
early stages of disease when there are high virus bur-
dens and the immune system has generated neither a
cell-mediated nor a humoral response against the virus.
In this study, we examined the neuroinvasive nature of
pathogenic and nonpathogenic SHIVs at the early stages
of infection. One of the two viruses utilized in this study
was the previously characterized uncloned, cell-free vi-
rus SHIV50OLNV, which was isolated from a macaque that
developed neurological disease and contains a trun-
cated Vpu but an intact Nef (McCormick-Davis et al.,
2000; Singh et al., 2001). The second virus was the
molecularly cloned virus SHIVKU-1bEGFP, which does not
encode for a Vpu and has an interrupted Nef due to the
in-frame insertion of the egfp gene 210 bases within the
nef gene. This virus was previously used in neutralization
assays but this is the first report analyzing it in vivo
(Singh et al., 2001). Our rationale for examining macaque
infection with SHIVKU-1bEGFP was (a) to determine whether
a SHIV with an interrupted nef can invade the CNS and
(b) to determine whether a SHIV expressing EGFP could
be used as a marker to investigate the early stages of
infection in the CNS. A previous study evaluated the use
of an SIV expressing EGFP as a marker to identify in-
fected cells both in vitro and in vivo (Alexander et al.,
1999). Their results demonstrated it was difficult to re-
cover fluorescent cells after 3 weeks postinoculation in
macaques. Sequence analysis of viral variants isolated 8
weeks postinoculation indicated that the egfp gene had
been deleted, suggesting that lentiviruses expressing
EGFP could be a useful tool for short-term studies (Al-
exander et al., 1999).
Our results clearly show that both the pathogenic
SHIV50OLNV and the vpu-deleted, nef-interrupted SHIVKU-
1bEGFP were actively replicating in the lymphoid organs of
all three macaques. This is based on the ability to detect
both viruses in these organs. There appeared to be a
higher virus burden of SHIV50OLNV when comparing the
number of cells producing infectious cytopathic virus
versus the number of fluorescent cells as well as the
distribution of the viruses in the visceral organs by PCR
analysis. This was confirmed with macaques inoculated
with either SHIV50OLNV or SHIVKU-1bEGFP. This is not alto-
gether surprising considering that previous studies have
shown that inoculation of nef-deleted SIVmac239 into ma-
caques results in lower virus burdens and reduced dis-
ease (Kestler et al., 1991; Chakrabarti et al., 1991). We
also examined the distribution of the two viruses in the
CNS at 2 weeks postinoculation. Previously, it had been
shown that viral sequences could be recovered from the
CNS of pig-tailed and rhesus macaques inoculated with
SHIV at end-stage disease (Raghavan et al., 1997). De-
spite the presence of viral sequences in the CNS of
pig-tailed macaques, none of these animals developed
SHIV-induced neurological disease (Raghavan et al.,
1997). However, we and others have shown that pig-
tailed macaques can develop neurological disease fol-
lowing inoculation with SHIV or SIV (Raghavan et al.,
1997; Liu et al., 1999; McCormick-Davis et al., 2000; Zink
et al., 1997, 1999). Our results indicated that SHIV50OLNV
entered the CNS within 2 weeks postinoculation as evi-
denced by the presence of viral gag sequences in 13 to
15 regions of the three macaques, suggesting that
SHIV50OLNV was distributed throughout the CNS. In addi-
tion, we were able to detect the presence of 2-LTR
circles in several regions of the CNS, indicating that
active viral replication was occurring in the CNS at 2
weeks postinoculation. The heterogenous nature of the
two LTR sequences may have been due to the
SHIVKU-1bEGFP as the 2-LTR sequences isolated from ma-
caques inoculated with SHIV50OLNV alone showed a ho-
mogenous 2-LTR PCR product (data not shown) and may
reflect the instability of the SHIVKU-1bEGFP with its EGFP
gene. Since our results indicate that it was maintained
up to 2 weeks postinoculation, we examined the CNS for
the expression of EGFP. Although we were not able to
directly visualize fluorescence in CNS tissues (data not
shown), we were able to use nested PCR to detect the
presence of the egfp gene in some regions of the CNS in
all the macaques analyzed. In contrast to the widespread
distribution of SHIV50OLNV, PCR analysis of tissue DNA
extracted from CNS regions indicated that SHIVKU-1bEGFP
had a more limited distribution with only two to four
regions positive for egfp, which we confirmed by South-
ern blot analysis of nef sequences amplified from the
different CNS regions of the three macaques. In order to
rule out the possibility that SHIV50OLNV infection had facil-
itated the entry of SHIVKU-1bEGFP into the CNS, two ma-
caques were inoculated with either SHIVKU-1bEGFP or
SHIV50OLNV. As expected, macaques inoculated with
SHIV50OLNV had a widespread distribution of virus and
2-LTR circle sequences were detected in a number of
regions of the CNS. Similar to macaques inoculated with
both viruses, macaques inoculated with SHIVKU-1bEGFP had
a more limited distribution in the CNS. Taken together,
these results indicate that both viruses were neuroinva-
sive.
Similar to previous SIV studies, our results also indi-
cated that one macaque, CB4W, had signs of meningitis
within 2 weeks postinoculation. However, the salient
histological change observed in all three macaques in-
oculated with both viruses was a reactive astrocytosis.
Astrocytosis, characterized by the proliferation of astro-
cytes, altered morphology of astrocytes, and increased
immunoreactivity (and hence expression) of GFAP, is
commonly observed in SIV- and SHIV-infected macaques
with end-stage encephalitis and has been evidenced as
early as 1 week postinoculation in a rhesus macaque
inoculated with SIV (Chakrabarti et al., 1991; Raghavan et
al., 1997; McCormick-Davis et al., 2000). Whether this
observed astrocytosis is due to SHIV infection of astro-
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cytes is under investigation. However, we have recently
shown that SHIV50OLNV is capable of infecting a human
astrocytoma cell line and causing up-regulation of GFAP
expression (Singh et al., unpublished observations). To
confirm that the observed astrocytosis was due to the
SHIV50OLNV, macaques were inoculated with either virus.
Our results indicate that the observed meningitis and
astrocytosis were due to SHIV50OLNV. This is supported by
the results of a previous study in which animals inocu-
lated with a pathogenic SIV showed neurological le-
sions, whereas none of the animals inoculated with a
nonpathogenic virus displayed lesions in the CNS (Lack-
ner et al., 1994). These results are similar to those from
a study that demonstrated that rhesus macaques inocu-
lated with pathogenic but nonneurovirulent SIVmac239
exhibited increased immunoreactivity at 14 days postin-
oculation (Gonzalez et al., 2000) and supports the utility
of using the SHIV/macaque model in the study of neu-
roAIDS.
This study demonstrates that neither a full-length Nef
nor Vpu is required for neuroinvasion. Both viruses with
an intact nef and viruses with an interrupted nef were
present both in lymphoid organs and in various regions
of the CNS, although the virus with a nonfunctional nef
gene was detected in fewer regions. However, the ability
to amplify egfp gene sequences from the CNS of all three
macaques provided evidence that this virus was able to
invade the CNS. The widespread distribution of the
SHIV50OLNV, the meningitis observed in one macaque, and
the massive astrocytosis seen in all three macaques are
due to the invasion and replication of this virus in the
CNS. The CNS has been proposed to be a potential
reservoir for HIV (Pierson et al., 2000). As this study has
shown that viruses expressing an interrupted nef are still
capable of crossing the blood–brain barrier and invading
the CNS at early times after inoculation, this raises a
major concern with regard to the design of live, attenu-
ated vaccines. Previous studies with SIV and SHIV have
demonstrated that vaccine virus and challenge virus can
undergo recombination events which in some cases
resulted in a more virulent strain (Wooley et al., 1997;
Gundlach et al., 2000). Further, in a study which exam-
ined the sequences of viral variants from autopsy sam-
ples of HIV patients with encephalitis, different recombi-
nation events appeared to have occurred in different
regions of the brain, suggesting that not only can recom-
bination occur when distinct viruses coinfect an individ-
ual but also that recombination can occur between dif-
ferent quasispecies originating from the initial infection
(Morris et al., 1999). The detection of SHIVKU-1bEGFP in the
CNS of all three macaques suggests that a gene-deleted
live vaccine may still cross the blood–brain barrier and
serve as a potential reservoir and suggests that more
studies are needed to evaluate the neuroinvasive nature
of attenuated viruses prior to their use as vaccines.
MATERIALS AND METHODS
Cells, plasmids, and viruses
Cells from the C8166 cell line were used as indicator
cells to measure the infectivity and cytopathicity of the
viruses used in this study. C8166 cells were maintained
in RPMI 1640, supplemented with 10 mM HEPES buffer,
pH 7.3, 2 mM glutamine, 5 g/ml gentamicin, and 10%
fetal bovine serum (R10FBS). The derivation of SHIV50OLNV
and SHIVKU-1bEGFP has been described previously (McCor-
mick-Davis et al., 2000; Singh et al., 2001).
Macaques analyzed in this study
Three pig-tailed macaques (AX67, CB4R, and CB4W)
were inoculated intravenously with 1 ml of undiluted
supernatant from C8166-grown stocks of SHIV50OLNV and 1
ml of undiluted supernatant from C8166-grown stocks of
the molecular clone SHIVKU-1bEGFP, each containing ap-
proximately 104 TCID50 per milliliter. Macaques CM4M
and CM58 were inoculated with approximately 104
TCID50 of SHIVKU-1bEGFP and macaques CM59 and CM6G
were inoculated with approximately 104 TCID50 of
SHIV50OLNV. Blood was collected approximately every 3
days in EDTA. At two weeks postinoculation, all animals
in this study were exsanguinated and perfused with 1.0
liter of saline at the time of euthanasia. All aspects of the
animal studies were performed according to the institu-
tional guidelines for animal care and use at University of
Kansas Medical Center.
Processing of blood and tissue samples
The PBMCs were prepared by centrifugation on Ficoll-
Hypaque gradients as described previously (Joag et al.,
1996). Tenfold dilutions of PBMCs (106 cells/ml) were
inoculated into replicate cultures of C8166 cells in 24-
well plates and the cocultures were examined for devel-
opment of cytopathic effects as previously described
(McCormick-Davis et al., 2000). The same plates were
examined by fluorescence microscopy to determine the
number of cells producing fluorescence. Cells producing
infectious cytopathic virus and/or infectious fluorescent
virus in the blood were reported as the number of in-
fected cells/106 PBMCs.
PCR analysis of visceral organs and CNS tissues for
the presence of viral sequences
SHIV gag. Visceral organs (kidney, liver, lung, ileum,
spleen, thymus, and inguinal and mesenteric lymph
nodes) were collected and DNA was isolated as previ-
ously described (McCormick-Davis et al., 2000). The CNS
from infected macaques was taken at necropsy and
dissected into the following regions: frontal cortex, pari-
etal cortex, occipital cortex, motor cortex, temporal cor-
tex, corpus callosum, hippocampus, basal ganglia, mid-
brain, pons, medulla, cerebellum, cervical spinal cord,
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thoracic spinal cord, and lumbar spinal cord, and DNA
was isolated as previously described (McCormick-Davis
et al., 2000). We used nested PCR to determine whether
SIV gag sequences were present in the DNA isolated
from the various tissues (Joag et al., 1994). In the first
round, SIV oligonucleotide primers used were 5-GAT-
GGGCGTGAGAAACTCCGTCTT-3 (sense) and 5-CCTC-
CTCTGCCGCTAGATGGTGCTGTTG-3 (antisense), which
are complementary to bases 1052 to 1075 and 1423 to
1450 of the SIVmac239 gag gene, respectively (Regier and
Desrosiers, 1990). The PCR amplification was performed
using the following conditions: denaturation at 92°C for 1
min, annealing at 55°C for 1 min, and primer extension at
72°C for 3 min. To increase the sensitivity of the reaction,
1 l of the first PCR product was used as a template for
a second amplification using the same conditions. The
nested SIV primers used were 5-GTTGAAGCATGTAG-
TATGGGCAGC-3 (sense) and 5-GCCTCAGGGCAGCG-
GAACCGCTCA-3 (antisense), which are complementary
to bases 1142 to 1165 and 1356 to 1382 of SIVmac239,
respectively. Samples were amplified for another 35 cy-
cles as described above. Following the second round of
amplification, a 10-l aliquot was removed and run on a
1.5% agarose gel and bands were visualized by staining
with ethidium bromide.
Detection of SHIV LTR circles. Examination of 2-LTR
circular DNA provides a view of active viral replication
due to the presence of a viral DNA form that is structur-
ally distinct and known to have a short half-life in infected
cells (Pauza et al., 1994; Zazzi et al., 1997; Teo et al., 1997;
Panther et al., 1998; Sharkey et al., 2000; Sharkey and
Stevenson, 2001). We analyzed the DNA isolated from
kidney, liver, lung, spleen, thymus, and inguinal and mes-
enteric lymph nodes and the 15 regions of the CNS for
the presence of 2-LTR circular forms of DNA, as previ-
ously described (McCormick-Davis et al., 2000). The oli-
gonucleotides used in the first round were 5-ATT-
TCGCTCTGTATTCAGTCGCTCTGC-3 (U5 region) and 5-
CCTCCTGTGCCTCATCTGATACATTTAC-3 (U3 region),
which correspond to bases 10,335 to 10,361 and 180 to
153 of the SHIV genome, respectively. The PCR amplifi-
cation was performed using the following conditions:
denaturation at 92°C for 1 min, annealing at 55°C for 1
min, and primer extension at 72°C for 3 min. One micro-
liter of the first PCR product was used as a template for
a second amplification using the same conditions. The
oligonucleotide primers used for the second round were
5-AGGTTCTCTCCAGCACTAGCAGGTAGAGC-3 (U5 re-
gion) 5-TTGGGTATCTAATTCCTGGTCCTGAG-3 (U3 re-
gion; opposite strand; 456), which correspond to bases
10,389 to 10,417 and 120 to 95 of the SHIV genome,
respectively. Samples were amplified for another 35 cy-
cles as described above. Following the second round of
amplification, a 10-l aliquot was removed and run on a
1.5% agarose gel and bands were visualized by staining
with ethidium bromide.
EGFP sequences. As the detection of the above se-
quences demonstrates the presence of either virus, we
next wanted to look for a gene unique to SHIVKU-1bEGFP. We
analyzed the DNA isolated from the kidney, liver, lung,
spleen, thymus, and inguinal and mesenteric lymph nodes
as well as the 15 regions of the CNS. We utilized nested
PCR to determine whether sequences for the EGFP gene
were present in the various tissues. For the first round,
oligonucleotides were designed to span the NcoI site
where the egfp gene was inserted into the viral nef gene:
5-GAATACTCCATGGATGAGCAAGGGCG-3 (sense) and
5-AGCTGGGTCTCTCCATGGTAGCGACCG-3 (antisense).
The PCR amplification was performed using the following
conditions: denaturation at 92°C for 1 min, annealing at
60°C for 1 min, and primer extension at 72°C for 3 min. To
increase the sensitivity of the reaction, 1 l of the first PCR
product was used as a template for a second amplification
using the same conditions. The second-round oligonucle-
otides used were 5-TGAACCGCATCGAGCTGAAGGG-3
(sense) and 5-AGGAGTACCAGGAGCTGCTCAAC-3 (anti-
sense), corresponding to positions 433 through 455 and 718
through 740 of the EGFP gene, respectively. Samples were
amplified for another 35 cycles as described above. Follow-
ing amplification, a 10-l aliquot was removed, run on a 2%
agarose gel, and visualized by staining with ethidium bro-
mide. The predicted product from the PCR is 308 bp.
Viral load assay. The virus loads in the CNS tissues
were determined using a quantitative PCR assay modi-
fied from a PCR-infected cell assay previously described
(Joag et al., 1994; Stephens et al., 1998a). In this assay, 1
g of total cellular DNA isolated from tissues was sub-
jected to a series of 10-fold dilutions such that samples
contained from 100 ng to 10 fg (less than 1 copy of
chromosomal DNA). These samples were used in nested
PCRs that amplified either the -actin gene of the cell (a
single-copy gene) or the gag gene from SIVmac239. Am-
plification of either gene using the primers previously
described was shown to detect one copy of each gene
(Joag et al., 1994). Thus amplification of the -actin gene
determined the number of genome equivalents in each
sample while amplification with the gag primers deter-
mined the number of viral copies per number of genome
equivalents. The values were expressed as the number
of viral copies per 106 genome equivalents.
Southern blot analysis of nef sequences
For amplification of nef, the following oligonucleotide
primers were used. For the first round of PCR, oligonu-
cleotide primers 5-CGGACCGACCTACAATATGGGTGG-
AGCTATTTC-3 (sense) and 5-ACATCCCCTTGTGGA-
AAGTCCCTGCTGTTT-3 (antisense) were used. These
two primers are complementary to nucleotides 9432 to
9464 of the SHIVKU-1b genome (Narayan et al., 1999;
McCormick-Davis et al., 2000) and 9868 to 9898 of the
SIVmac239 genome (Regier and Desrosiers, 1990), respec-
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tively. For the second round, oligonucleotide primers
5-ATGGGTGGAGCTATTTCCATGAGGCGGTCC-3 (sense)
and 5-TCAGCGAGTTTCCTTCTTGTCAGCCAT-3 (anti-
sense) were used. These two primers are complementary
to nucleotides 9077 to 9106 and 9842 to 9868 of the
SIVmac239 genome (Regier and Desrosiers, 1990), respec-
tively. The amplification conditions were the same as de-
scribed above. Following amplification, a 10-l aliquot was
removed, run on a 1% agarose gel, and visualized by stain-
ing with ethidium bromide. The gel was denatured by soak-
ing in 0.5 N NaOH, 1.5 M NaCl for 1 h and neutralized in 0.5
M Tris–HCl (pH 7.5), 1.5 M NaCl for 1 h. The DNA was
transferred to nitrocellulose by capillary action in 10 SSC
overnight at room temperature. The membrane was al-
lowed to air-dry and the DNA was cross-linked to the
membrane by exposure to ultraviolet light. Following the
immobilization of the DNA, the membrane was incubated
with prehybridization solution (50% formamide, 5 SSC, 5
Denhardt’s solution, 200 g/ml salmon sperm DNA, and
0.5% SDS) for 1 h at 42°C. The prehybridization solution
was removed and the membrane was incubated with a
32P-labeled egfp probe overnight at 42°C. The probe was
removed and the membrane was washed two times for 10
min in 2 SSC, 0.5% SDS, once for 30 min in 0.2 SSC,
0.5% SDS, and once for 30 min in 0.1 SDS, 0.5% SDS at
68°C. The nitrocellulose membrane was allowed to air-dry
and was exposed to X-ray film using standard autoradio-
graphic procedures.
Immunohistochemistry, visualization of EGFP in
tissues, and histology
The left halves of the brains from infected and unin-
fected control macaques were fixed by immersion in 2%
paraformaldehyde, blocked in a standard coronal plane
into 6-mm blocks, cryoprotected in 30% sucrose in 0.1 M
phosphate buffer, and frozen-sectioned at 50 m using a
sliding microtome. For examination of lymphoid organs
and brain for the expression of EGFP, fresh frozen sec-
tions were cut and directly examined for the expression
of EGFP under a fluorescence microscope. Selected
sections were stained for GFAP using mouse anti-GFAP
monoclonal antibody diluted 1:500 (MAB3402, Chemicon
International Inc., Temecula, CA). MHC-II was visualized
by staining the same series of sections with mouse
monoclonal anti-MHC-II antibody (LN-3, ICN Biomedical,
Cosa Mesa, CA) diluted 1:200. Following the reaction
with primary antibodies, sections were reacted with an
anti-mouse biotinylated secondary antibody and staining
was visualized using an ABC kit and following the man-
ufacturer’s protocols (Vector Laboratories, Burlingame,
CA). Briefly, sections were washed free-floating (1 in
PBS, pH 7.5) and equilibrated in PBS, quenched for en-
dogenous peroxidase (in 0.5% H2O2 for 30 min), and
blocked in 10% normal horse serum (in PBS) for 1 h.
Sections were incubated in primary antibody (1:200)
overnight at room temperature, washed (3 in PBS for 10
min each), and incubated in biotinylated horse anti-
mouse IgG (1:200) for 1 h. Sections were washed 5 times
in PBS, rinsed in 0.5% Triton X-100 for 30 s, and incubated
with DAB for 2–10 min until suitable color development
was detected. Controls included immunostaining brain
sections from control macaques without CNS disease.
Controls for nonspecific staining consisted of incubation
of the sections with buffer in the place of primary anti-
body. Sections were rinsed in distilled water, mounted on
gelatin-coated glass slides, dried overnight at room tem-
perature, dehydrated through alcohol and xylene, and
covered with coverslips as per routine histological pro-
cedures.
For histopathological examination of visceral organs
and CNS, tissues were fixed in 10% neutral buffered
formalin, washed in water, and dehydrated in an ascend-
ing series of alcohol before being cleared in xylene and
embedded in paraffin. Then 3- to 5-m-thick sections
were stained with hematoxylin and eosin using standard
procedures and examined under the microscope for the
presence of histological lesions.
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